At Biogenomics, R&D efforts are primarily in Recombinant DNA Technologies. Biogenomics’ has a team of molecular biologists, microbiologists, protein chemists and fermentation technologists to develop a range of recombinant products such as therapeutic proteins and enzymes. Research in Recombinant DNA based drug discovery is mainly in five principle areas:

• Molecular Cloning and Expression
• Microbiology and Strain Improvement
• Fermentation Technology
• Protein Folding
• Protein Purification Strategies